A novel mRNA-based patient selection strategy identifies fibroblast growth factor receptor (FGFR) inhibitor-sensitive tumors: Results from rogaratinib Phase-1 study

Autor:	Ross A. Soo, Martin Schuler, D-W. Kim, D. Tai, Sebastian Bender, Matthias Ocker, A. Navarro, Byoung Chul Cho, Markus Joerger, Peter Ellinghaus, Philippe A. Cassier, Prabhu Rajagopalan, Juergen Wolf, Heike Richly, Stuart Ince, Cyrus Sayehli
Rok vydání:	2017
Předmět:	Messenger RNA Oncology business.industry Fibroblast growth factor receptor 2 Fibroblast growth factor receptor Selection strategy Cancer research Medicine Hematology Fibroblast growth factor receptor 3 business
Zdroj:	Annals of Oncology. 28:v126-v127
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx367.013
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::031ba93e68dfa2f3c1a04722bd9b3ba1 https://doi.org/10.1093/annonc/mdx367.013 Zobrazit plný text záznamu